[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"severe-native-calcific-aortic-stenosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:severe-native-calcific-aortic-stenosis":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100646149","validation-of-anatomy-specific-aortic-valve-implantation-guided-by-software-using-encantor-100646149",false,"NCT07696182","Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR","VOYAGER CE Clinical Trial : Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR","VOYAGER CE","Inclusion Criteria:\n\n* Subject identified as appropriate for transcatheter heart valve intervention therapy for the treatment of symptomatic, severe aortic stenosis.\n* Subject is of legal age for consent (18 years old).\n* Willing to return for required follow-up visits and assessments\n\nExclusion Criteria:\n\n* Pregnant or nursing subjects.\n* Need for emergency surgery for any reason\n* Anatomic or comorbid conditions\n* Currently participating in an investigational drug or device study that has not reached the primary endpoint or may confound the results of this trial","ALL","18 Years",{"count":20,"type":21},150,"ESTIMATED","INTERVENTIONAL",[24],"NA","VOYAGER CE Clinical Study using the Encantor TAVI System.",[27,28],"Severe Native Calcific Aortic Stenosis","Symptomatic Heart Disease Due to Severe Native Calcific Aortic Stenosis",[30,31],"transcatheter valve replacement therapy","symptomatic heart disease","NOT_YET_RECRUITING","2026-07-06",{"date":35,"type":36},"2026-07-10","ACTUAL",{"date":38,"type":21},"2026-11-30",{"date":40,"type":21},"2038-12-30",{"name":42,"class":43},"Abbott Medical Devices","INDUSTRY"]